The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 27th 2024
Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.
The American Heart Association's Council on Clinical Cardiology presented its highest honor, the James B. Herrick Award for Outstanding Achievement in Clinical Cardiology, to Kanu Chatterjee, M.B., of the University of Iowa, "in grateful recognition of his distinguished and productive career benefitting physicians and their patients worldwide."
Read More
The American Heart Association awarded its Clinical Research Prize for 2014 to Judith S. Hochman, M.D., of NYU Langone Medical Center "for exceptional leadership of landmark clinical trials profoundly impacting formulation of national practice guidelines for the management of ischemic heart disease."
Read More
The American Heart Association today awarded its Basic Research Prize for 2014 to Ande Terzic, M.D., Ph.D., of the Mayo Clinic "for pioneering applications of emerging technologies to advance the diagnosis and treatment of cardiovascular disorders." Terzic received the prize during opening ceremonies of the AHA's Scientific Sessions 2014 at Chicago's McCormick Place. Association President Elliott Antman of Boston presented the prize, a citation and $5,000 honorarium, recognizing outstanding achievement in basic cardiovascular science.
Read More
International Pharmaceutical Federation Mobilizes Ebola Response
November 15th 2014With a mission to help pharmacists throughout the world prevent the potential spread of the Ebola virus, the International Pharmaceutical Federation has launched a suite of resources to advise community pharmacists on the threat.
Read More
FDA Grants Priority Review to Bipolar Indication for Schizophrenia Drug
November 14th 2014Actavis's supplemental New Drug Application for asenapine to treat manic or mixed episodes related to bipolar disorder in pediatric patients has been accepted by the FDA and given priority review status.
Read More